Keytruda Adverse Event Report 2018

$19.99

This report includes data from the FDA’s Adverse Events Reports for 2018.  We removed reports where the subject of the report was taking only this drug. This report provides the following fields:

  • ID
  • Patient Summary
  • Patient Gender
  • Patient Age
  • Drug Products
  • Drug Reactions

Description

Kyprolis (carfilzomib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Kyprolis is used to treat multiple myeloma. It is sometimes given with other medicines when treating relapsed multiple myeloma. Kyprolis is usually given after other treatments have failed.https://www.drugs.com/kyprolis.html